Favre, Guillaume
Richardson, Jonathan L.
Moore, Alan
Geissbühler, Yvonne
Jehl, Valentine
Oliver, Alison
Shechtman, Svetlana
Diav-Citrin, Orna
Berlin, Maya
De Haan, Tal
Baud, David
Panchaud, Alice
Mor, Anil
Sabidó, Meritxell
de Souza, Sabrina
Chambers, Christina
van Rijt-Weetink, Yrea R. J.
van Puijenbroek, Eugène P.
Yates, Laura M.
Girardin, François
Stellfeld, Michael
Winterfeld, Ursula http://orcid.org/0000-0002-9926-7164
Funding for this research was provided by:
Innovative Medicines Initiative (821520)
University of Lausanne
Article History
Accepted: 15 November 2023
First Online: 19 December 2023
Declarations
:
: Open access funding provided by University of Lausanne. The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 821520. This joint undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Program and EFPIA. The research leading to these results was conducted as part of the ConcePTION Consortium. This paper only reflects personal views of the stated authors.
: GF, JLR, AO, SS, YRJvRW, DB, AP, CC, EvP, ODC, MB, TDH, FG and UW declare no conflicts of interest, no other financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years, and no previous or ongoing relationships or activities that could appear to have influenced the submitted work. A. Moore was a Novartis associate whilst working on this manuscript and other aspects of the ConcePTION project and holds shares in Novartis Pharma AG. YG and VJ are employees of Novartis Pharma AG. M. Stellfeld is an employee of Novo Nordisk A/S. M. Sabidó and SdS are employees of Merck Healthcare KGaA. LMY received honoraria from Sanofi Genzyme South Africa on two occasions in 2021 for (1) an advisory board presentation on genetic testing in Gaucher’s disease (April 2021) and (2) a conference lecture on genetic testing in the cardiac clinic’ (September 2021). A. Mor is an employee of Sanofi and holds shares in Sanofi.
: Not applicable.
: Not applicable.
: Not applicable.
: Data will be available from the corresponding author to third parties interested in reusing them upon reasonable request.
: Not applicable.
: GF, JLR, A. Moore, YG, AO, SS, ODC, MB, A. Mor, M. Sabidó, YRJvRW, EvP, LMY, M. Stellfeld and UW contributed to the study conception and design. GF, JLR, A. Moore, YG, AO, SS, ODC, MB, TDH, A. Mor, M. Sabidó, SdS, CC, YRJvRW, EvP, LMY, FG, M. Stellfeld and UW contributed to the acquisition of data. GF, JLR, M, Stellfeld and UW contributed to the data analysis. GF, JLR, A. Moore, YG, VJ, AO, SS, ODC, MB, TDH, DB, AP, A. Mor, M Sabidó, SdS, CC, YRJvRW, EvP, LMY, FG, M. Stellfeld and UW contributed to interpretation of the data, and drafting and revising of the manuscript for intellectual content. All authors read and approved the final version.